Subscribe

What are you looking for?

Main Menu

明報新聞網

和黃醫藥治轉移性胃癌新藥獲內地藥監批 沃瑞沙適應者增至三個

Future Wealths
Future Wealths
2 7 月, 2026
One Min Read
1 Views
0 Comments
和黃醫藥（中國）（0013 ）宣布，沃瑞沙（ORPATHYS，賽沃替尼/ savolitinib ）的新藥上市申請獲中國國家藥品監督管理局附條件批准，用於治療經過至少2種系統治療後失敗的MET基因擴增的局部晚期或轉移性胃癌或胃食道連接部（GC/GEJ ）腺癌成人患者。

原文: https://finance.mingpao.com/fin/instantf/20260702/1782987934259/%E5%92%8C%E9%BB%83%E9%86%AB%E8%97%A5%E6%B2%BB%E8%BD%89%E7%A7%BB%E6%80%A7%E8%83%83%E7%99%8C%E6%96%B0%E8%97%A5%E7%8D%B2%E5%85%A7%E5%9C%B0%E8%97%A5%E7%9B%A3%E6%89%B9-%E6%B2%83%E7%91%9E%E6%B2%99%E9%81%A9%E6%87%89%E8%80%85%E5%A2%9E%E8%87%B3%E4%B8%89%E5%80%8B%22%20target=%22blank

Last Update: 2 7 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept